X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (753438) 753438
Publication (50586) 50586
Book Review (2497) 2497
Magazine Article (1119) 1119
Book Chapter (616) 616
Conference Proceeding (483) 483
Dissertation (337) 337
Government Document (310) 310
Book / eBook (142) 142
Report (137) 137
Data Set (46) 46
Paper (44) 44
Web Resource (30) 30
Trade Publication Article (9) 9
Presentation (5) 5
Journal / eJournal (3) 3
Newspaper Article (3) 3
Reference (3) 3
Archival Material (1) 1
Electronic Resource (1) 1
Exam (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (706300) 706300
follow-up studies (604570) 604570
female (532778) 532778
male (512436) 512436
middle aged (380450) 380450
adult (354222) 354222
aged (277475) 277475
index medicus (272662) 272662
treatment outcome (179698) 179698
adolescent (152749) 152749
surgery (139144) 139144
retrospective studies (135006) 135006
follow-up (131384) 131384
child (109048) 109048
time factors (101171) 101171
aged, 80 and over (96550) 96550
risk factors (94144) 94144
prospective studies (90650) 90650
prognosis (87409) 87409
child, preschool (69234) 69234
young adult (63113) 63113
cardiac & cardiovascular systems (55751) 55751
oncology (53042) 53042
infant (50604) 50604
care and treatment (45850) 45850
analysis (45219) 45219
cohort studies (44586) 44586
clinical neurology (44506) 44506
recurrence (42527) 42527
mortality (42465) 42465
medicine & public health (41320) 41320
survival rate (40916) 40916
children (40324) 40324
abridged index medicus (39242) 39242
risk assessment (38767) 38767
orthopedics (38546) 38546
research (38375) 38375
risk (38144) 38144
cancer (37766) 37766
pediatrics (37530) 37530
severity of illness index (37036) 37036
health aspects (37031) 37031
management (36939) 36939
incidence (36902) 36902
diagnosis (33826) 33826
prevalence (32533) 32533
neoplasm staging (32176) 32176
psychiatry (31515) 31515
age factors (31215) 31215
infant, newborn (30719) 30719
radiography (30097) 30097
surveys and questionnaires (29859) 29859
therapy (28225) 28225
medicine, general & internal (27660) 27660
disease (27319) 27319
survival (26534) 26534
tomography, x-ray computed (24870) 24870
combined modality therapy (24866) 24866
survival analysis (24735) 24735
magnetic resonance imaging (23415) 23415
urology & nephrology (23335) 23335
postoperative complications (22778) 22778
quality of life (22760) 22760
outcomes (22645) 22645
gastroenterology & hepatology (22163) 22163
ophthalmology (22152) 22152
disease progression (21752) 21752
article (21542) 21542
longitudinal studies (20648) 20648
reoperation (20594) 20594
pregnancy (20564) 20564
predictive value of tests (19863) 19863
diagnosis, differential (19726) 19726
transplantation (19389) 19389
risk-factors (19377) 19377
patients (19126) 19126
complications (18999) 18999
radiology, nuclear medicine & medical imaging (18784) 18784
epidemiology (18229) 18229
respiratory system (18010) 18010
women (17979) 17979
multivariate analysis (17925) 17925
public, environmental & occupational health (17724) 17724
medical research (17342) 17342
dentistry, oral surgery & medicine (17224) 17224
peripheral vascular disease (17121) 17121
proportional hazards models (17049) 17049
case-control studies (16989) 16989
animals (16663) 16663
studies (16610) 16610
neurosciences (16553) 16553
patient outcomes (16404) 16404
experience (16304) 16304
age (16284) 16284
methods (16073) 16073
prevention (15908) 15908
chronic disease (15901) 15901
usage (15893) 15893
sex factors (15860) 15860
trial (15686) 15686
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Robarts - Stacks (28) 28
OISE - Stacks (22) 22
UTL at Downsview - May be requested (21) 21
Online Resources - Online (8) 8
UofT at Mississauga - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Scarborough - Stacks (5) 5
Holland Bloorview Kids Rehabilitation - Stacks (4) 4
Law (Bora Laskin) - Stacks (3) 3
OISE - Reference (3) 3
Victoria University Emmanuel College - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Criminology - Stacks (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
OISE - May be requested in 6-10 wks (1) 1
OISE - Microfiche (1) 1
Robarts - Government Pubs (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (674297) 674297
German (21284) 21284
Russian (13349) 13349
French (12559) 12559
Chinese (9389) 9389
Spanish (5148) 5148
Japanese (4546) 4546
Polish (4512) 4512
Italian (4250) 4250
Portuguese (1120) 1120
Danish (913) 913
Czech (724) 724
Norwegian (534) 534
Hungarian (489) 489
Hebrew (375) 375
Dutch (365) 365
Finnish (361) 361
Bulgarian (300) 300
Swedish (299) 299
Turkish (289) 289
Romanian (286) 286
Korean (234) 234
Lithuanian (133) 133
Ukrainian (120) 120
Slovak (99) 99
Croatian (68) 68
Serbian (63) 63
Slovenian (16) 16
Icelandic (15) 15
Afrikaans (8) 8
Greek (8) 8
Persian (7) 7
Arabic (3) 3
Bosnian (3) 3
Thai (3) 3
Armenian (1) 1
Indonesian (1) 1
Malay (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2014, Volume 189, Issue 4, pp. 408 - 418
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 590 - 598
Summary Background Currently, crizotinib is the only drug that has been approved for treatment of ALK -rearranged non-small-cell lung cancer (NSCLC). We aimed... 
Hematology, Oncology and Palliative Medicine | FUSION | GENE | ONCOLOGY | C-MET | KINASE | CRIZOTINIB | ANAPLASTIC LYMPHOMA | INHIBITOR | ROS1 | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Piperidines - pharmacokinetics | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Adenocarcinoma - drug therapy | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Receptor Protein-Tyrosine Kinases - genetics | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Gene Rearrangement | Carbazoles - pharmacokinetics | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Oncology, Experimental | Research | College teachers | Lung cancer, Non-small cell | Drug approval | Cancer
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 160, Issue 1, pp. 49 - 57.e1
The identification of asymptomatic individuals at risk for near-term atherothrombotic events to ensure optimal preventive treatment remains a challenging goal.... 
Cardiovascular | C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | PLAQUE | PREDICTION | Risk Assessment - methods | Myocardial Infarction - epidemiology | Tomography, Emission-Computed, Single-Photon - methods | Prognosis | Prospective Studies | Follow-Up Studies | United States | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Atherosclerosis - epidemiology | Incidence | Coronary Angiography - methods | Aged, 80 and over | Atherosclerosis - diagnosis | Female | Stroke - epidemiology | Myocardial Infarction - etiology | Stroke - prevention & control | Cross-Sectional Studies | Atherosclerosis - complications | Biomarkers - blood | Stroke - etiology | Primary Prevention - methods | Aged | Myocardial Infarction - prevention & control | CT imaging | Medical colleges | Medical research | RNA | Aneurysms | Diagnostic imaging | Preventive health services | Prevention | Risk assessment | Atherosclerosis | Medicine, Experimental | Cardiology | Medicine, Preventive | Health insurance | Stroke | Heart attacks | Medical imaging | Nuclear magnetic resonance--NMR | Medicare | Mortality | Objectives | Cardiovascular disease | Gender | Studies | Disease prevention | Health maintenance organizations--HMOs | Health Insurance Portability & Accountability Act 1996-US | Womens health | Biomarkers | Tomography | Population | Health risk assessment | Age
Journal Article
Circulation, ISSN 0009-7322, 08/2009, Volume 120, Issue 6, pp. 502 - 509
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 2016, Volume 23, Issue 5, pp. 363 - 369
Journal Article
Circulation, ISSN 0009-7322, 07/2014, Volume 130, Issue 4, pp. 298 - 307
BACKGROUND—Fibroblast growth factor-23 (FGF-23) is a hormone that promotes urinary phosphate excretion and regulates vitamin D metabolism. Circulating FGF-23... 
fibroblast growth factors | minerals | atrial fibrillation | chronic | renal insufficiency | UNITED-STATES | CARDIAC & CARDIOVASCULAR SYSTEMS | renal insufficiency, chronic | EVENTS | VASCULAR DYSFUNCTION | RENAL-FUNCTION | RISK | LEFT-VENTRICULAR HYPERTROPHY | COMMUNITY | CYSTATIN-C | PARATHYROID-HORMONE | PERIPHERAL VASCULAR DISEASE | CHRONIC KIDNEY-DISEASE | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Fibroblast Growth Factor 3 - physiology | Male | Renal Insufficiency, Chronic - complications | Vitamin D - biosynthesis | Renal Insufficiency, Chronic - epidemiology | Ventricular Remodeling | Ventricular Dysfunction, Left - blood | Aged, 80 and over | Female | Heart Failure - epidemiology | Ethnic Groups - statistics & numerical data | Glomerular Filtration Rate | Hypertrophy, Left Ventricular - blood | Comorbidity | Phosphates - pharmacokinetics | Risk Factors | Proportional Hazards Models | Ventricular Dysfunction, Left - etiology | Fibroblast Growth Factor 3 - blood | Ventricular Dysfunction, Left - physiopathology | Atrial Fibrillation - blood | Renal Insufficiency, Chronic - blood | Phosphates - metabolism | Atrial Fibrillation - epidemiology | Atrial Fibrillation - etiology | Vitamin D - analogs & derivatives | Aged | Demographic aspects | Atrial fibrillation | Atherosclerosis | Physiological aspects | Fibroblast growth factors | Research | Cardiovascular diseases | chronic kidney disease | fibroblast growth factor | mineral
Journal Article